Dr. Holcombe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
149 Beaumont Av
Heath Sciences Research Facility - 326 Cancer Center
Burlington, VT 05405Phone+1 802-656-2207- Is this information wrong?
Education & Training
- Baruch CollegeMBA, 2015
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1986 - 1989
- Brigham and Women's HospitalResidency, Internal Medicine, 1983 - 1986
- Rutgers New Jersey Medical SchoolClass of 1983
- Duke UniversityBA, Zoology, Chemistry, Magna Cum Laude, 1979
Certifications & Licensure
- CA State Medical License 1997 - Present
- NY State Medical License 2010 - 2025
- VT State Medical License 2021 - 2024
- HI State Medical License 2017 - 2022
- MA State Medical License 1986 - 2016
- FL State Medical License 2014 - 2016
- LA State Medical License 1989 - 2005
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Care Coordination Educational Intervention Study for Patients From Rural Areas With Early Stage Cancer Start of enrollment: 2023 Mar 31
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 56 citationsGenistein combined with FOLFOX or FOLFOX–Bevacizumab for the treatment of metastatic colorectal cancer: phase I/II pilot studySofya Pintova, Sirish Dharmupari, Erin Moshier, Nicole Zubizarreta, Celina Ang, Randall F. Holcombe> ;Cancer Chemotherapy and Pharmacology. 2019 Jun 15
- 15 citationsChemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel DiseaseJordan E. Axelrad, Anuja Kriplani, Umut Ozbek, Noam Harpaz, Jean-Frederic Colombel, Steven H. Itzkowitz, Randall F. Holcombe, Celina Ang> ;Clinical Colorectal Cancer. 2017 Sep 1
- 9 citationsME-143 Is Superior to Genistein in Suppression of WNT Signaling in Colon Cancer Cells.Sofya Pintova, Kestutis Planutis, Marina Planutiene, Randall F. Holcombe> ;Anticancer Research. 2017 Apr 1
- Join now to see all
Press Mentions
- University of Vermont Cancer Center to Offer Innovative New Cancer TreatmentFebruary 23rd, 2023
- UVM Cancer Center Rolls Out Custom-Made ImmunotherapyFebruary 22nd, 2023
Hospital Affiliations
- University of Vermont Medical CenterBurlington, Vermont
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: